Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
Nuri Peker,1 Özge Çeliker Tosun2 1Department of Obstetrics and Gynecology, İstinye University Bahçeşehir Liv Hospital, Istanbul, Turkey; 2School of Physiotherapy, Dokuz Eylul University, Izmir, Turkey Objective: In this study, we investigated the relationship between...
Saved in:
Main Authors: | Peker N, Çeliker Tosun Ö |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/197f56d52f0b4d27b4c60e5afad4d148 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
by: Luigi Gennari, et al.
Published: (2010) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009) -
Olive oil in the prevention and treatment of osteoporosis after artificial menopause
by: Liu HL, et al.
Published: (2014) -
Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial
by: Lai CL, et al.
Published: (2013) -
BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
by: Ma Z, et al.
Published: (2016)